NO20022728D0 - Nye aminopropylfosfinsyrer - Google Patents

Nye aminopropylfosfinsyrer

Info

Publication number: NO20022728D0
Authority: NO; Norway
Prior art keywords: novel; aminopropylphosphinic acids; aminopropylphosphinic; acids; novel aminopropylphosphinic
Prior art date: 1999-12-09

Application number

NO20022728A

Other languages

English (en)

Other versions

NO329595B1 (no

NO20022728L (no

Inventor

Thomas Elebring

Peter Guzzo

Anders Holmen

Thomas Olsson

Marianne Swansson

Sverker Von Unge

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-09

Filing date

2002-06-07

Publication date

2002-06-07

2000-10-09 Priority claimed from SE0003640A external-priority patent/SE0003640D0/xx

2002-06-07 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-06-07 Publication of NO20022728D0 publication Critical patent/NO20022728D0/no

2002-08-07 Publication of NO20022728L publication Critical patent/NO20022728L/no

2010-11-22 Publication of NO329595B1 publication Critical patent/NO329595B1/no

Links

ZTHNRNOOZGJLRR-UHFFFAOYSA-N chembl112203 Chemical class NCCCP(O)=O ZTHNRNOOZGJLRR-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
- C07F9/4808—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
- C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Addiction (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Nutrition Science (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20022728A 1999-12-09 2002-06-07 Nye aminopropylfosfinsyrer, farmasoytiske formuleringer inneholdende slike, samt mellomprodukter til fremstilling av slike NO329595B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9904508A SE9904508D0 (sv)	1999-12-09	1999-12-09	New compounds
SE0003640A SE0003640D0 (sv)	2000-10-09	2000-10-09	New compounds
PCT/SE2000/002426 WO2001042252A1 (en)	1999-12-09	2000-12-04	New aminopropylphosphinic acids

Publications (3)

Publication Number	Publication Date
NO20022728D0 true NO20022728D0 (no)	2002-06-07
NO20022728L NO20022728L (no)	2002-08-07
NO329595B1 NO329595B1 (no)	2010-11-22

Family

ID=26655259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022728A NO329595B1 (no)	1999-12-09	2002-06-07	Nye aminopropylfosfinsyrer, farmasoytiske formuleringer inneholdende slike, samt mellomprodukter til fremstilling av slike

Country Status (33)

Country	Link
US (5)	US6576626B2 (no)
EP (2)	EP1484333A1 (no)
JP (2)	JP3914435B2 (no)
KR (1)	KR100689144B1 (no)
CN (1)	CN1198832C (no)
AR (1)	AR030541A1 (no)
AT (1)	ATE282043T1 (no)
AU (1)	AU780459B2 (no)
BR (1)	BR0016253A (no)
CA (1)	CA2397583C (no)
CZ (1)	CZ20021983A3 (no)
DE (1)	DE60015796T2 (no)
DK (1)	DK1240172T3 (no)
EE (1)	EE05067B1 (no)
ES (1)	ES2230174T3 (no)
HK (2)	HK1048321B (no)
HU (1)	HUP0300301A3 (no)
IL (2)	IL149840A0 (no)
IS (1)	IS2231B (no)
MX (1)	MXPA02005536A (no)
MY (1)	MY125414A (no)
NO (1)	NO329595B1 (no)
NZ (1)	NZ519376A (no)
PL (1)	PL201789B1 (no)
PT (1)	PT1240172E (no)
RU (1)	RU2260595C2 (no)
SE (1)	SE9904508D0 (no)
SI (1)	SI1240172T1 (no)
SK (1)	SK286904B6 (no)
TW (1)	TWI228510B (no)
UA (1)	UA71649C2 (no)
WO (1)	WO2001042252A1 (no)
ZA (1)	ZA200204127B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
CN1491106A (zh) *	2001-02-05	2004-04-21	�޲��ء��߶�ķ˹��	食管活动性功能紊乱和胃-食管反流性疾病的治疗方法
AR033779A1 (es) *	2001-06-08	2004-01-07	Astrazeneca Ab	Compuestos utiles en la enfermedad de reflujo
SE0201939D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination
SE0201940D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination II
SE0401653D0 (sv)	2004-06-24	2004-06-24	Astrazeneca Ab	New compounds
SE0402462D0 (sv) *	2004-10-08	2004-10-08	Astrazeneca Ab	New process
WO2006050471A2 (en)	2004-11-03	2006-05-11	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006050472A2 (en) *	2004-11-03	2006-05-11	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
US20060160777A1 (en) *	2004-12-27	2006-07-20	Anders Lehmann	New use of GABAbeta receptor agonists
AU2006327317B2 (en)	2005-12-23	2010-11-25	Astrazeneca Ab	GABA-B receptor modulators
BRPI0620372A2 (pt)	2005-12-23	2011-11-08	Astrazeneca Ab	composto, composição farmaceutica, e, uso de um composto
WO2008033572A1 (en)	2006-09-15	2008-03-20	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
ES2373255T3 (es) *	2007-05-04	2012-02-01	Astrazeneca Ab	Proceso para s�?ntesis de �?cidos alquilfosf�?nicos mediante iniciación de una amina y un aminóxido.
US20100317626A1 (en) *	2007-07-25	2010-12-16	Astrazeneca Ab	The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD
WO2009082345A1 (en) *	2007-12-21	2009-07-02	Astrazeneca Ab	Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
EP2235026A4 (en) *	2007-12-21	2011-08-17	Astrazeneca Ab	NEW PROCESS FOR THE PREPARATION OF (2R) - (3-AMINO-2-FLUORO-PROPYL) PHOSPHIC ACID FORM A
PE20091176A1 (es) *	2007-12-21	2009-09-03	Astrazeneca Ab	Nueva forma cristalina c del acido (2r)-(3-amino-2-fluoropropil)fosfinico
WO2009145716A1 (en) *	2008-05-28	2009-12-03	Astrazeneca Ab	New pharmaceutical formulation useful in gerd therapy
WO2010051883A1 (de)	2008-11-05	2010-05-14	Clariant International Ltd	Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung
CN102186864A (zh)	2008-11-07	2011-09-14	科莱恩金融(Bvi)有限公司	利用丙烯酸衍生物制备二烷基次膦酸、二烷基次膦酸酯和二烷基次膦酸盐的方法，以及它们的用途
DE102008056341A1 (de)	2008-11-07	2010-05-12	Clariant International Limited	Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
CN102171226B (zh)	2008-11-11	2015-02-11	科莱恩金融(Bvi)有限公司	利用烯丙基化合物制备单烯丙基官能化的二烷基次膦酸、其盐或酯的方法以及它们的用途
DE102008060035A1 (de) *	2008-12-02	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de)	2008-12-04	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
DE102008063668A1 (de)	2008-12-18	2010-07-01	Clariant International Limited	Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
US9181487B2 (en)	2008-12-18	2015-11-10	Clariant Finance (Bvi) Limited	Process for preparing ethylenedialkylphosphinic acids, esters and salts by means of acetylene and use thereof
DE102008063627A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
DE102008063642A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
DE102008064003A1 (de)	2008-12-19	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en)	2010-03-17	2011-09-22	INSERM (Institut National de la Santé et de la Recherche Médicale)	Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
WO2012009646A1 (en)	2010-07-15	2012-01-19	Xenoport, Inc.	Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH449046A (de)	1963-07-09	1967-12-31	Ciba Geigy	Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en) *	1984-10-12	1984-11-21	Ciba Geigy Ag	Chemical compounds
AU594424B2 (en)	1986-01-03	1990-03-08	University Of Melbourne, The	Gastro-oesophageal reflux composition
US4740332A (en) *	1986-05-12	1988-04-26	E. R. Squibb & Sons, Inc.	Process for preparing phosphonous acids
GB8820266D0 (en)	1988-08-26	1988-09-28	Smith Kline French Lab	Compounds
GB8911017D0 (en)	1989-05-13	1989-06-28	Ciba Geigy Ag	Substituted aminoalkylphosphinic acids
US5567840A (en)	1989-05-13	1996-10-22	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
US5281747A (en)	1989-05-13	1994-01-25	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
US5006560A (en)	1989-12-20	1991-04-09	Schering Corporation	Use of GABA-B selective agonists as anti-tussive agents
IL114631A (en) *	1990-06-22	1998-12-06	Novartis Ag	Anti-epileptic preparations containing antagonists of BABAG
FR2663934B1 (fr)	1990-06-27	1994-06-03	Adir	Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
GB9125615D0 (en) *	1991-12-02	1992-01-29	Wyeth John & Brother Ltd	Amines
AU662404B2 (en) *	1992-05-08	1995-08-31	Novartis Ag	Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
FR2722192A1 (fr)	1994-07-06	1996-01-12	Adir	Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en)	1994-10-14	1994-11-30	Glaxo Group Ltd	Medicaments
SE9603408D0 (sv) *	1996-09-18	1996-09-18	Astra Ab	Medical use
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists
SE9904507D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds

1999
- 1999-12-09 SE SE9904508A patent/SE9904508D0/xx unknown
2000
- 2000-04-12 UA UA2002064507A patent/UA71649C2/uk unknown
- 2000-11-27 TW TW089125135A patent/TWI228510B/zh not_active IP Right Cessation
- 2000-12-04 CZ CZ20021983A patent/CZ20021983A3/cs unknown
- 2000-12-04 AT AT00983634T patent/ATE282043T1/de active
- 2000-12-04 DK DK00983634T patent/DK1240172T3/da active
- 2000-12-04 BR BR0016253-1A patent/BR0016253A/pt not_active IP Right Cessation
- 2000-12-04 KR KR1020027007355A patent/KR100689144B1/ko not_active IP Right Cessation
- 2000-12-04 SI SI200030561T patent/SI1240172T1/xx unknown
- 2000-12-04 US US09/786,219 patent/US6576626B2/en not_active Expired - Fee Related
- 2000-12-04 WO PCT/SE2000/002426 patent/WO2001042252A1/en active IP Right Grant
- 2000-12-04 RU RU2002113909/04A patent/RU2260595C2/ru not_active IP Right Cessation
- 2000-12-04 NZ NZ519376A patent/NZ519376A/en not_active IP Right Cessation
- 2000-12-04 DE DE60015796T patent/DE60015796T2/de not_active Expired - Lifetime
- 2000-12-04 SK SK764-2002A patent/SK286904B6/sk not_active IP Right Cessation
- 2000-12-04 MX MXPA02005536A patent/MXPA02005536A/es active IP Right Grant
- 2000-12-04 PT PT00983634T patent/PT1240172E/pt unknown
- 2000-12-04 PL PL364795A patent/PL201789B1/pl not_active IP Right Cessation
- 2000-12-04 EP EP04021533A patent/EP1484333A1/en not_active Withdrawn
- 2000-12-04 CA CA2397583A patent/CA2397583C/en not_active Expired - Fee Related
- 2000-12-04 HU HU0300301A patent/HUP0300301A3/hu unknown
- 2000-12-04 AU AU20364/01A patent/AU780459B2/en not_active Ceased
- 2000-12-04 ES ES00983634T patent/ES2230174T3/es not_active Expired - Lifetime
- 2000-12-04 JP JP2001543550A patent/JP3914435B2/ja not_active Expired - Fee Related
- 2000-12-04 EE EEP200200286A patent/EE05067B1/xx not_active IP Right Cessation
- 2000-12-04 AR ARP000106418A patent/AR030541A1/es active IP Right Grant
- 2000-12-04 EP EP00983634A patent/EP1240172B1/en not_active Expired - Lifetime
- 2000-12-04 CN CNB008168989A patent/CN1198832C/zh not_active Expired - Fee Related
- 2000-12-04 IL IL14984000A patent/IL149840A0/xx active IP Right Grant
- 2000-12-07 MY MYPI20005746A patent/MY125414A/en unknown
2002
- 2002-05-23 ZA ZA200204127A patent/ZA200204127B/xx unknown
- 2002-06-06 IS IS6408A patent/IS2231B/is unknown
- 2002-06-07 NO NO20022728A patent/NO329595B1/no not_active IP Right Cessation
2003
- 2003-01-17 HK HK03100457.3A patent/HK1048321B/zh not_active IP Right Cessation
- 2003-04-04 US US10/406,838 patent/US6841698B2/en not_active Expired - Fee Related
- 2003-07-29 HK HK03105473A patent/HK1053125A1/xx not_active IP Right Cessation
2004
- 2004-01-01 IL IL149840A patent/IL149840A/en not_active IP Right Cessation
- 2004-12-16 US US11/016,543 patent/US7034176B2/en not_active Expired - Fee Related
2006
- 2006-04-07 US US11/400,021 patent/US7807658B2/en not_active Expired - Fee Related
- 2006-06-27 JP JP2006175983A patent/JP2006306885A/ja active Pending
2007
- 2007-07-12 US US11/776,648 patent/US20080146836A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP3914435B2 (ja)	2007-05-16
HUP0300301A2 (hu)	2003-06-28
PL201789B1 (pl)	2009-05-29
TWI228510B (en)	2005-03-01
UA71649C2 (en)	2004-12-15
JP2003516407A (ja)	2003-05-13
NZ519376A (en)	2003-11-28
WO2001042252A1 (en)	2001-06-14
MXPA02005536A (es)	2004-09-10
US6576626B2 (en)	2003-06-10
HK1048321A1 (en)	2003-03-28
CN1198832C (zh)	2005-04-27
AU2036401A (en)	2001-06-18
CZ20021983A3 (cs)	2002-11-13
IL149840A (en)	2006-04-10
AR030541A1 (es)	2003-08-27
EP1240172B1 (en)	2004-11-10
EP1484333A1 (en)	2004-12-08
HUP0300301A3 (en)	2008-12-29
PT1240172E (pt)	2005-02-28
ZA200204127B (en)	2003-08-25
NO329595B1 (no)	2010-11-22
BR0016253A (pt)	2002-08-27
ATE282043T1 (de)	2004-11-15
IS6408A (is)	2002-06-06
CA2397583C (en)	2010-11-09
MY125414A (en)	2006-07-31
US20020156053A1 (en)	2002-10-24
US20070021393A1 (en)	2007-01-25
US7807658B2 (en)	2010-10-05
US20050137414A1 (en)	2005-06-23
RU2002113909A (ru)	2004-01-10
EP1240172A1 (en)	2002-09-18
JP2006306885A (ja)	2006-11-09
SK7642002A3 (en)	2002-12-03
KR100689144B1 (ko)	2007-03-08
CN1409716A (zh)	2003-04-09
CA2397583A1 (en)	2001-06-14
US6841698B2 (en)	2005-01-11
AU780459B2 (en)	2005-03-24
SE9904508D0 (sv)	1999-12-09
ES2230174T3 (es)	2005-05-01
RU2260595C2 (ru)	2005-09-20
US7034176B2 (en)	2006-04-25
US20030220303A1 (en)	2003-11-27
EE05067B1 (et)	2008-08-15
SK286904B6 (sk)	2009-07-06
IS2231B (is)	2007-04-15
HK1053125A1 (en)	2003-10-10
DK1240172T3 (da)	2005-02-14
HK1048321B (zh)	2005-09-30
US20080146836A1 (en)	2008-06-19
IL149840A0 (en)	2002-11-10
KR20020060992A (ko)	2002-07-19
SI1240172T1 (en)	2005-02-28
DE60015796T2 (de)	2005-11-03
EE200200286A (et)	2003-08-15
NO20022728L (no)	2002-08-07
PL364795A1 (en)	2004-12-13
DE60015796D1 (de)	2004-12-16

Legal Events

Date	Code	Title	Description
2012-07-23	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
DK1240172T3 (da)	2005-02-14	Nye aminopropylphosphinsyrer
NO20014518L (no)	2001-09-17	Nye forbindelser
DK1202994T3 (da)	2004-08-02	Nye forbindelser
NO20021436L (no)	2002-06-19	Nye forbindelser
NO20033715L (no)	2002-04-30	Nye sammensetninger
NO20020810D0 (no)	2002-02-19	Nye fenylpiperaziner
NO20015949D0 (no)	2001-12-05	Mono- og disubstituerte 3-propyl-gamma-amino-smörsyrer
NO20015383L (no)	2001-12-21	Nye forbindelser
DK1237857T3 (da)	2004-09-20	Nye Phenalkyloxyphenylderivater
NO20015074L (no)	2001-11-15	Nye sammensetninger
EE200100708A (et)	2003-02-17	Asendatud fenoksüäädikhapped
NO20003965D0 (no)	2000-08-04	Nye dihydroksyheksansyre-derivater
NO20022729D0 (no)	2002-06-07	Nye (aminopropyl-)metylfosfinsyrer
DK1317426T3 (da)	2006-01-09	Betal-thio-aminosyrer
NO995945D0 (no)	1999-12-03	Nye forbindelser
NO20015374D0 (no)	2001-11-02	Nye forbindelser
NO20013601D0 (no)	2001-07-20	Nye morfolinobenzamidsalter
NO20014629D0 (no)	2001-09-24	Nye forbindelser
NO20016273D0 (no)	2001-12-20	Nye forbindelser
DE60031553D1 (de)	2006-12-07	Optsche mediaplatten mit hoher datendichte
ATE251154T1 (de)	2003-10-15	Substituierte phenyluracile
NO991585D0 (no)	1999-03-31	Trekkanordning
SE9902933D0 (sv)	1999-08-18	Novel process
SE9901903D0 (sv)	1999-05-26	Novel process
SE9901902D0 (sv)	1999-05-26	Novel process